Candonilimab Plus Bevacizumab for Patients With Advanced HCC Who Progressed on A+T

Clinical trial NCT05760599 · UNKNOWN

Trial details

NCT number: NCT05760599
Sponsor: Shi Ming
Status: UNKNOWN
Phase: Phase 2
Study type: INTERVENTIONAL

Hepatocellular Carcinoma

Start date: 2023-02-27
Primary completion: 2024-01-01
Enrollment: 30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.